Kengo Gohchi

838 total citations
29 papers, 473 citations indexed

About

Kengo Gohchi is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Kengo Gohchi has authored 29 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Rheumatology, 11 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Immunology. Recurrent topics in Kengo Gohchi's work include Systemic Lupus Erythematosus Research (14 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Kengo Gohchi is often cited by papers focused on Systemic Lupus Erythematosus Research (14 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Kengo Gohchi collaborates with scholars based in Japan, France and United Kingdom. Kengo Gohchi's co-authors include Noriko Saitoh, Moritaka Gotoh, Juzo Matsuda, Miyo Tsukamoto, J Matsuda, Kazuo Kawasugi, Mutsuyoshi Kazama, Takeshi Abe, Tatsuo Shimosawa and Yutaka Yatomi and has published in prestigious journals such as Clinical Infectious Diseases, Annals of the Rheumatic Diseases and British Journal of Haematology.

In The Last Decade

Kengo Gohchi

27 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kengo Gohchi Japan 13 294 212 86 84 63 29 473
Moritaka Gotoh Japan 15 287 1.0× 278 1.3× 78 0.9× 100 1.2× 69 1.1× 59 595
Barbara Montaruli Italy 13 313 1.1× 256 1.2× 69 0.8× 57 0.7× 48 0.8× 32 444
L. La Rosa Italy 7 325 1.1× 123 0.6× 58 0.7× 149 1.8× 73 1.2× 14 605
Tatsuya Atsumi Japan 14 529 1.8× 336 1.6× 161 1.9× 197 2.3× 93 1.5× 31 754
Miao Qi Australia 11 159 0.5× 116 0.5× 77 0.9× 109 1.3× 40 0.6× 27 452
L. Iannaccone Italy 9 239 0.8× 106 0.5× 28 0.3× 132 1.6× 45 0.7× 14 450
Lena Innala Sweden 7 520 1.8× 77 0.4× 109 1.3× 105 1.3× 53 0.8× 11 630
Thomas Sailer Austria 10 163 0.6× 308 1.5× 34 0.4× 43 0.5× 20 0.3× 14 450
Miguel Ángel Plasín Spain 5 281 1.0× 152 0.7× 26 0.3× 95 1.1× 55 0.9× 7 394
Irama Villar Spain 8 502 1.7× 95 0.4× 55 0.6× 177 2.1× 47 0.7× 14 634

Countries citing papers authored by Kengo Gohchi

Since Specialization
Citations

This map shows the geographic impact of Kengo Gohchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kengo Gohchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kengo Gohchi more than expected).

Fields of papers citing papers by Kengo Gohchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kengo Gohchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kengo Gohchi. The network helps show where Kengo Gohchi may publish in the future.

Co-authorship network of co-authors of Kengo Gohchi

This figure shows the co-authorship network connecting the top 25 collaborators of Kengo Gohchi. A scholar is included among the top collaborators of Kengo Gohchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kengo Gohchi. Kengo Gohchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shimosawa, Tatsuo, Kengo Gohchi, Yutaka Yatomi, & Toshiro Fujita. (2007). Effectiveness of Add-On Low-Dose Diuretics in Combination Therapy for Hypertension: Losartan/Hydrochlorothiazide vs. Candesartan/Amlodipine. Hypertension Research. 30(9). 831–837. 28 indexed citations
2.
Matsuda, J, Tsutomu Sanaka, Aya Nishizawa, Moritaka Gotoh, & Kengo Gohchi. (2002). Two antiprothrombin antibodies against prothrombin and prothrombin–phosphatidyl serine show partial but not total identity. Blood Coagulation & Fibrinolysis. 13(8). 697–702. 19 indexed citations
4.
5.
Matsuda, J, Noriko Saitoh, Moritaka Gotoh, et al.. (1996). PHOSPHATTDYL SERINE-DEPENDENT ANTIPROTHROMBIN ANTIBODY IS EXCLUSIVE TO PATIENTS WITH LUPUS ANTICOAGULANT. Lara D. Veeken. 35(6). 589–591. 36 indexed citations
6.
Matsuda, Juzo, et al.. (1996). Negligible synergistic effect of β2-glycoprotein I on the reactivity of antioxidized low-density lipoprotein antibody to oxidized low-density lipoprotein. American Journal of Hematology. 52(2). 114–116. 2 indexed citations
7.
Matsuda, Juzo, et al.. (1996). Buffer may be the critical factor in measurement of anti-prothrombin antibody on a γ-ray-irradiated plate by enzyme-linked immunosorbent assay. American Journal of Hematology. 53(4). 242–244. 1 indexed citations
8.
Matsuda, Juzo, Kengo Gohchi, Kazuo Kawasugi, et al.. (1995). Inhibitory activity of anti‐β2‐glycoprotein I antibody on factor va degradation by activated‐protein C and its cofactor protein S. American Journal of Hematology. 49(1). 89–91. 24 indexed citations
9.
Matsuda, Juzo, et al.. (1995). Resistance to activated protein C activity of an anti‐/2 ‐glycoprotein I antibody in the presence of β‐glycoprotein I. British Journal of Haematology. 90(1). 204–206. 22 indexed citations
10.
Matsuda, Juzo, Noriko Saitoh, Kengo Gohchi, Moritaka Gotoh, & Miyo Tsukamoto. (1994). Detection of Beta-2-Glycoprotein-l-Dependent Antiphospholipid Antibodies and Anti-Beta-2-Glyco-protein-l Antibody in Patients with Systemic Lupus Erythematosus and in Patients with Syphilis. International Archives of Allergy and Immunology. 103(3). 239–244. 5 indexed citations
11.
Matsuda, Juzo, et al.. (1994). Anti‐annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody. American Journal of Hematology. 47(1). 56–58. 94 indexed citations
12.
Kimura, Satoshi, Kengo Gohchi, Katsuyuki Fukutake, et al.. (1994). Phase III Clinical Trial of KRN8601 (rhG-CSF) for Neutropenia in Patients with Human Immunodeficiency Virus Infection. Kansenshogaku zasshi. 68(9). 1093–1104. 1 indexed citations
13.
Matsuda, Juzo, et al.. (1993). β2-glycoprotein I -dependent and -independent anticardiolipin antibody in patients with end-stage renal disease. Thrombosis Research. 72(2). 109–117. 20 indexed citations
14.
Matsuda, J, Miyo Tsukamoto, Kengo Gohchi, et al.. (1993). Serum Adenosine Deaminase 2 and Neopterin Levels Are Increased in a Majority of Hemophiliacs Irrespective of Infection with Human Immunodeficiency Virus Type 1. Clinical Infectious Diseases. 16(2). 260–264. 2 indexed citations
15.
Matsuda, Juzo, et al.. (1993). Anticoagulant activity of an anti‐β2‐glycoprotein I antibody is depentent on the presence of β2‐glycoprotein I. American Journal of Hematology. 44(3). 187–191. 7 indexed citations
16.
Matsuda, Juzo, Noriko Saitoh, Kengo Gohchi, Moritaka Gotoh, & Miyo Tsukamoto. (1993). Distinguishing β2‐glycoprotein I dependent (systemic lupus erythematosus type) and independent (syphilis type) anticardiolipin antibody with Tween 20. British Journal of Haematology. 85(4). 799–802. 21 indexed citations
20.
Kazama, Mutsuyoshi, et al.. (1981). Abnormal plasminogen, a case of recurrent thrombosis. Thrombosis Research. 21(4-5). 517–522. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026